Launch Event of the European Alliance for Transformative Therapies


The European Alliance for Transformative Therapies was officially launched at a virtual event on 8 December 2020. The event was co-hosted by MEPs Ondřej Knotek (Renew Europe, Czech Republic), Claudia Gamon (Renew Europe, Austria) and Tomislav Sokol (EPP, Croatia).

The event saw the Alliance present its Call to Action, which makes a series of recommendations with a view to facilitating access to potentially life-saving cell and gene therapies. The Alliance calls for the integration of key priorities and considerations for cell and gene therapies into the implementation of the Pharmaceutical Strategy for Europe and other relevant EU healthcare initiatives.

The launch event brought together multiple stakeholders to discuss key themes around cell and gene therapies. Experts elaborated on key issues around bridging the gap between patients and innovation and improving the regulatory context for cell and gene therapies.

The discussion focused on the following key issues:

  1. The need for healthcare professionals’ education and adequate infrastructure for the provision of cell and gene therapies.
  2. The importance of conducting efficient Advanced Therapeutic Medicinal Products clinical trials.
  3. The need to build acceptability for Real-World Evidence.
  4. The dissemination of best practices on innovative payment solutions for cell and gene therapies.

@TRANSFORM_CGT on Twitter Follow us →

TRANSFORM member MEP @nicogoncas speakes at the @EUBloodAlliance event on the new SoHO Regulation. R&D is advancing with SoHO-based therapies that have the potential to change lives of #patients. #MEPsforATMPs https://t.co/q1l7n8EwWr
25 January at 11:51am
SAVE THE DATES! TRANSFORM is back in 2️⃣0️⃣2️⃣3️⃣ and ready to shape the future of cell and gene therapies! 🗓️1 June (15:00 - 17:00) Policy webinar on the Pharmaceutical Package, online 🗓️24 October (afternoon) Conference in the European Parliament, In-person, Brussels #MEPsforATMPs
09 January at 1:17pm
Interesting event @alliancerm today! With the EU Pharma legislation review, the new HTA Regulation and the EHDS, the EU has an opportunity to encourage innovation & ensure that ATMPs are a central part of the EU’s healthcare landscape @Kympouropoulos @susanasolisp #MEPsforATMPs https://t.co/ODkSdMePW9
29 November at 9:07pm